Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.13 USD | +1.43% | -3.18% | -38.44% |
09/05 | Nephros, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
09/05 | Transcript : Nephros, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Sales 2024 * | 15.7M 1.31B | Sales 2025 * | 18.05M 1.51B | Capitalization | 22.14M 1.85B |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | - 0 | EV / Sales 2024 * | 1.41 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.23 x |
P/E ratio 2024 * |
-42
x | P/E ratio 2025 * |
52.5
x | Employees | 31 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.77% |
Latest transcript on Nephros, Inc.
1 day | +1.43% | ||
1 week | -3.18% | ||
Current month | -4.48% | ||
1 month | +6.50% | ||
3 months | -39.14% | ||
6 months | +1.92% | ||
Current year | -38.44% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Banks
CEO | Chief Executive Officer | 49 | 31/23/31 |
Judy Krandel
DFI | Director of Finance/CFO | 59 | 01/11 |
Alfred Vargas
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Amron
BRD | Director/Board Member | 67 | 19/07/19 |
Oliver Spandow
BRD | Director/Board Member | 52 | 10/18/10 |
Alisa Lask
BRD | Director/Board Member | 53 | 08/19/08 |
Date | Price | Change | Volume |
---|---|---|---|
15/24/15 | 2.13 | +1.43% | 9 771 |
13/24/13 | 2.1 | 0.00% | 8,811 |
10/24/10 | 2.1 | -5.19% | 10,663 |
09/24/09 | 2.215 | +2.07% | 5,084 |
08/24/08 | 2.17 | -1.36% | 22,780 |
Delayed Quote Nasdaq, May 15, 2024 at 01:06 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.44% | 22.14M | |
+15.00% | 8.98B | |
+39.90% | 2.55B | |
-13.95% | 1.02B | |
+22.88% | 853M | |
-5.04% | 750M | |
+16.99% | 675M | |
+14.99% | 669M | |
+17.28% | 602M | |
-17.29% | 587M |
- Stock Market
- Equities
- NEPH Stock